icon-    folder.gif   Conference Reports for NATAP  
  20th Conference on Retroviruses and
Opportunistic Infections
Atlanta, GA March 3 - 6, 2013
Back grey_arrow_rt.gif
Triple Combination Therapy Telaprevir vs Boceprevir, in Spain, Early Results, in Mono- and Coinfected
Triple Combination Therapy for Hepatitis C with Telaprevir Exhibits Higher Early Antiviral Potency than with Boceprevir Regardless HIV Status
  Reported by Jules Levin
CROI 2013
Jose M Benito1, Ivana Maida2, Clara Sanchez1, Norma I Rallon1, Antonio Aguilera3, Pablo Labarga1, Pablo Barreiro1 and Vincent Soriano1 1Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain; 2Institute of Infectious Diseases, University of Sassari, Sassari, Italy; 3Hospital de Conxo, Santiago de Compostela, Spain